Cookies are used for the functionality of our web site. For more information
please see our Privacy policy or Ok thanks

video reports

COVID-19 updates

16 July 2021

SARS-CoV-2 resurgence in EU and EEA related to relaxation of non-pharmaceutical interventions and increasing spread of Delta variant

There has been a 64.3% increase of weekly COVID-19 cases compared to last week, according to ECDC’s epidemic intelligence and TESSy data reported by EU and EEA countries, as of 15 July 2021. 

COVID-19 Response and Preparedness Seminar Series Webinar 1: TRIPS - recording available

The European Public Health Association (EUPHA) in collaboration with the French Public Health Association (Société Française de Santé Publique) (SFSP), and with the support of the EUPHA Health technology assessment section (EUPHA-HTA), are organising a series of events to raise awareness and to share the knowledge of experts on key aspects regarding: COVID-19 Preparedness and Response.

The first webinar of this series took place on July 6.
 The speakers presented and discussed the Trade-Related Aspects of Intellectual Property Rights (#TRIPS) Agreement, the relevance of a temporary waiver and of voluntary licensing, as well as knowledge transfer and vaccine distribution mechanisms. This first seminar also focused on the role of the European Union and of its Member States regarding these issues.

14 July 2021

EMA and ECDC update on COVID-19

10 July 2021

European Commission
Statement by President von der Leyen on the EU reaching the milestone of vaccine deliveries to vaccinate 70% of EU adults

8 July 2021

COVID-19 in children and the role of school settings in transmission - second update

The aim of this document is to provide an update on the knowledge surrounding the role of children in the transmission of SARS-CoV-2 and the role of schools in the COVID-19 pandemic, focusing in particular on the experience in EU/EEA countries since the beginning of the pandemic. This document also addresses transmission to and from staff in school settings, school-related mitigation measures including risk communication, testing, contact tracing, and the effectiveness and impacts of school closures. 

1 July 2021

European Commission
EU Digital COVID Certificate enters into application in the EU

As of July 1st, the EU Digital COVID Certificate Regulation enters into application. This means that EU citizens and residents will now be able to have their Digital COVID Certificates issued and verified across the EU. 21 Member States as well as Norway, Iceland and Liechtenstein had already started to issue certificates ahead of today's deadline, and five EU countries are starting today.

EUPHA, EUPHA-HTA, French Piblic Health Association
COVID-19 Response and Preparedness Seminar Series: TRIPS Waiver, Knowledge Transfer and Vaccine Distribution - 6 July

The European Public Health Association (EUPHA) in collaboration with the French Public Health Association (Société Française de Santé Publique) (SFSP), and with the support of EUPHA’s Health Technology Assessment Section (EUPHA-HTA), are organising a series of events to raise awareness and to share the knowledge of experts on key aspects regarding:
COVID-19 Preparedness and Response.
We are delighted to announce the first webinar of this series will take place on:
July 6, at 3:30 – 5 pm CEST (Brussels, Paris, Amsterdam) / 9:30 – 11 am EDT (New York)

Register now:

23 June 2021

Threat Assessment Brief: Implications for the EU/EEA on the spread of the SARS-CoV-2 Delta (B.1.617.2) variant of concern

The aim of this threat assessment brief is to assess potential public health implications of the spread of the SARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) for the European Union and European Economic Area (EU/EEA). 

17 June 2021

Resolve to Save Lives, Surgo Ventures
Increasing COVID-19 Vaccine Uptake - A Four-Step Framework to Promote Access, Acceptance and Equity

This guide provides a framework for identifying and mapping the most useful data sources onto learnings from community engagement to continuously build context-specific interventions and evaluate your success.

14 June 2021

Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA

This report provides an updated overview of the progress of national COVID-19 vaccination strategies in EU/EEA countries, including updates on: vaccine uptake overall and by target group; current vaccination phases and priority groups, as well as any adjustments made to priority groups during the rollout; vaccination strategies and policies in place; and the use of vaccination certificates and challenges countries face with the rollout and good practices to mitigate these challenges.

European Commission
EU clears way for the EU Digital COVID Certificate

Today, the Presidents of the three EU institutions, the European Parliament, the Council of the EU and the European Commission attended the official signing ceremony for the Regulation on the EU Digital COVID Certificate, marking the end of the legislative process. 

10 June 2021

European Parliament
Parliament calls for COVID-19 vaccine patent waiver

To accelerate global vaccine rollout, MEPs demand the temporary lifting of intellectual property rights protection for COVID-19 vaccines.

Rapid risk assessment: Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 15th update

9 June 2021

European Parliament
Parliament gives its final green light to the EU Digital COVID Certificate

MEPs completed today the legislative work on the EU digital COVID Certificate package to facilitate travel within the EU and contribute to the economic recovery. What you need to know:

  • The certificate will be issued free of charge by national authorities and be available in either digital or paper format containing a QR code.
  • The document will certify that a person has been vaccinated against COVID-19, has a recent negative test result or has recovered from the infection. In practice, these will be three distinct certificates.
  • A common EU framework will make certificates interoperable and verifiable across the European Union, as well as prevent fraud and forgery.
  • The system will apply from 1 July 2021 and be in place for 12 months. The certificate will not be a precondition for free movement and will not be considered a travel document.

8 June 2021

Virtual press briefing on COVID-19: situation in the WHO European Region

When: Thursday 10 June 2021, 11:00 Central European Summer Time (CEST)
WHO/Europe will hold its regular virtual press briefing with Dr Hans Henri P. Kluge, WHO Regional Director for Europe, and technical experts. The briefing will present a situation update on COVID-19 in the WHO European Region and answer media questions.
The virtual press briefing will be broadcast live on WHO/Europe’s Facebook account  and on its Twitter profile

4 June 2021

The BMJ Opinion
Coordination was the right path for the EU’s vaccine strategy, but lessons need to be learned

'It seems clear that future pandemics and other cross-border health threats will require increased cooperation on a European level—not just in the context of vaccines, but also in other areas of health policy. The European Commission has started to promote the idea of a European Health Union and individual member states are beginning to acknowledge that the bloc should be granted more power when it comes to health matters.'

Revolve to Save Lives by Vital Strategies
COVID-19: In-Depth Science Review

This science review is a snapshot of the new and emerging scientific evidence related to COVID-19 during the period specified. It is a review of important topics and articles.

3 June 2021

Reducing COVID 19 transmission and strengthening vaccine uptake among migrant populations in the EU/EEA

This report presents evidence on the impact of COVID-19 on migrant populations in EU/EEA countries; risk factors for increased COVID-19 exposure in migrant populations; and considerations for ensuring equitable access to the COVID-19 vaccine for migrant populations.

1 June 2021

Interim public health considerations for COVID-19 vaccination of adolescents in the EU/EEA

This technical report provides a set of interim public health considerations to support EU/EEA public health authorities taking decisions on the administration of COVID-19 vaccines to adolescents (12- to 18-year-olds).
The focus of this document is on the overall potential public health impact, rather than on the individual benefits and risks, of COVID-19 vaccination in adolescents.

31 May 2021

European Commission
Coronavirus: Commission proposes update to coordinated travel measures ahead of the summer

The European Commission has proposed an update to the Council Recommendation on the coordination of free movement restrictions in the EU, which were put in place in response to the COVID-19 pandemic.

Joint Research Centre
COVID-19: How a better understanding of airborne transmission is the key to break the chain of infection

In a new study published in May, JRC scientists propose to merge the two non-contact transmission modes, large-droplet and aerosol, into a unique non-contact airborne transmission mode. It is, according to them, essential to break the chain of infection, 

28 May 2021

Suspend intellectual property rights for covid-19 vaccines

'As we enter into a new era of global pandemics, we must fundamentally rethink the global intellectual property system. The ability to respond swiftly to global crises cannot be left to a handful of private companies in a few wealthy countries. We need a more cooperative global response to this and future public health emergencies.'

27 May 2021

COVID-19 situation update for the EU/EEA, as of 27 May 2021

26 May 2021

What does it mean to engage the public in the response to covid-19?

In this paper, the authors explain how governments and other authorities should respond to calls for public engagement in covid-19 response and recovery.

24 May 2021

Journal of Epidemiology and Community Health
Importance of population-based longitudinal studies to understanding the impact of COVID-19

The author discusses some of the important dimensions of the COVID-19 pandemic that population-based longitudinal studies are well placed to study.

20 May 2021

European Parliament
Getting a patent waiver is not enough, says WTO chief to Trade Committee

WTO Director-General Dr Ngozi Okonjo-Iweala said: “Getting the Intellectual Property rights waiver for vaccines will not be enough”. She listed three other routes: reducing export restrictions and reinforcing supply chains for vaccines, working with manufacturers to expand production, including in emerging countries with idle capacity such as Indonesia, South Africa, Thailand or Bangladesh, and transferring the necessary technology and expertise to produce the complicated vaccines.

Statement – COVID-19: A fragile progress

Dr Hans Henri P. Kluge, WHO Regional Director for Europe, highlights the progresses made in the fight again COVID-19, but also stresses the fragility of the whole process.

The use of antibody tests for SARS-COV-2 in the context of Digital Green Certificates

This brief technical note was developed at the request of the European Commission to inform the discussion on Digital Green Certificates to facilitate the safe and free movement of citizens within the EU during the COVID-19 pandemic.

19 May 2021

European Parliament
EU Covid-19 Certificate: a European solution for free testing is needed

EP negotiators want to use the Emergency Support Instrument in order to provide citizens with accessible and free of charge testing for the purpose of the new EU Covid-19 certificate. 

ECDC releases new dashboard on SARS-CoV-2 variants

A new dashboard released by ECDC now provides an overview of the proportion of SARS-CoV-2 variants of concern and variants of interest among sequenced samples in European Union (EU) and European Economic Area (EEA) countries, as well as sequencing volumes. It complements the data published in ECDC’s weekly country overview report. 

13 May 2021

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

In conclusion, vaccination with either one dose of BNT162b2 or ChAdOx1-S was associated with a significant reduction in symptomatic covid-19 in older adults, and with further protection against severe disease. Both vaccines showed similar effects. 

11 May 2021

International Health
Institutional and behaviour-change interventions to support COVID-19 public health measures: a review by the Lancet Commission Task Force on public health measures to suppress the pandemic

'To mitigate the negative impact of COVID-19 restrictions and build preparedness for future pandemics, political leaders at local, regional and global levels must weigh up the benefits and harms of restrictions on individual freedoms, tackle existing and emerging inequities, provide clear, consistent guidance to the public and strengthen capacity in research and the application of the analytical and behavioural sciences.'

10 May 2021

A global database of COVID-19 vaccinations

The authors present the Our World in Data COVID-19 vaccination dataset, a global public dataset that tracks the scale and rate of the vaccine rollout across the world. This resource aids policymakers and researchers in understanding the rate of current and potential vaccine rollout; the interactions with non-vaccination policy responses; the potential impact of vaccinations on pandemic outcomes such as transmission, morbidity and mortality; and global inequalities in vaccine access.

6 May 2021

Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA

This report provides an updated overview of the progress of national COVID-19 vaccination strategies in EU/EEA countries, including updates on: vaccine uptake overall and by target group; current vaccination phases and priority groups, as well as any adjustments made to priority groups during the rollout; vaccination strategies and policies in place; and the use of vaccination certificates and challenges countries face with the rollout and good practices to mitigate these challenges.

4 May 2021

COVID-19 Health System Response Monitor
Cross-Country Analysis: What strategies are countries using to get COVID-19 vaccines to people in hard-to-reach groups?

Hard-to-reach populations have disproportionately experienced the negative impacts of COVID-19; therefore, they are not only a crucial demographic for governments to vaccinate, but also require coordinated strategies to ensure they have equitable vaccine access. This analysis outlines the most commonly adopted strategies across the European Region.

29 April 2021

Joint Research Centre
From science to action: finding a common European approach for tracking SARS-CoV-2 and its variants in wastewater

It is seven in the evening and JRC scientist Bernd Gawlik is multitasking: he is preparing a dinner with a recipe originating from the German part of Silesia – the region his family is originally from – while drafting replies to a journalist on tracking COVID-19 with wastewater.

Global health and health workforce development: what to learn from COVID-19 on health workforce preparedness and resilience? 
Ellen Kuhlmann, Gilles Dussault, Tiago Correia

Public health competences through the lens of the COVID-19 pandemic: what matters for health workforce preparedness for global health emergencies?
Katarzyna Czabanowska, Ellen Kuhlmann

28 April 2021

New COVID-19 collection

To celebrate the European Immunization Week, the ECDC has created a new COVID-19 collection that will be updated weekly, as they publish new articles on the topic.

SARS-CoV-2 variants of concern pose a higher risk for hospitalisation and intensive care admission

A study coordinated by ECDC together with seven EU countries – Cyprus, Estonia, Finland, Ireland, Italy, Luxembourg, and Portugal – analysed data on the three VOC reported by the collaborating countries, and the research shows a higher risk for hospitalisation and intensive care admission.

The Lancet
SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties

'Countries that consistently aim for elimination—ie, maximum action to control SARS-CoV-2 and stop community transmission as quickly as possible—have generally fared better than countries that opt for mitigation—ie, action increased in a stepwise, targeted way to reduce cases so as not to overwhelm health-care systems.'

26 April 2021

International Journal of Health Policy and Management
Equitable and Effective Distribution of the COVID-19 Vaccines – A Scientific and Moral Obligation

As we continue to search for solutions to this pandemic, maintaining prior commitments to global solidarity and access through initiatives such as COVAX is clearly a prerequisite to stop this pandemic. National governments should be accountable for preparing the needed logistical measures to ensure an equitable, ethical and effective distribution, with priority given to the most at risk

22 April 2021

The Lancet Psychiatry
COVID-19 and suicide

'A professional consensus, in other words, is emerging concerning suicide and the pandemic. It refutes the use of suicide statistics to score political points (for example, about the wisdom of lockdowns), but it recognises the role that those in power can play in mitigating the economic and social factors that might increase the risk of suicide. It resists oversimplified narratives that reduce the complexities of mental distress to a simple count of deaths, but it asserts the importance of individual experience. The consensus insists on facts over sensationalist hearsay, but it is not complacent. And it emphasises that we are at a historic moment in which much is still uncertain, yet with effective monitoring systems a great deal can be known and acted on.'

Covid-19: What do we know about airborne transmission of SARS-CoV-2?

How COVID-19 spreads is one of the most debated questions of the pandemic. Chris Baraniuk explains what the evidence tells us about airborne transmission of the virus.

Journal of Migration and Health
Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review

The authors conclude that 'migrants in high-income countries are at high risk of exposure to, and infection with, COVID-19. These data are of immediate relevance to national public health and policy responses to the pandemic. Robust data on testing uptake and clinical outcomes in migrants, and barriers and facilitators to COVID-19 vaccination, are urgently needed, alongside strengthening engagement with diverse migrant groups.'

21 April 2021

Coronavirus Politics: The Comparative Politics and Policy of COVID-19

This book identifies key threads in the global comparative discussion that continue to shed light on COVID-19 and shape debates about what it means for scholarship in health and comparative politics. It is available open access in pdf and in epub.

The Lancet
Prisons need to be included in global and national vaccinations effort against COVID-19

'On a global scale, effective management of COVID-19 in custodial settings is key to stopping the spread of the virus. People in detention are more vulnerable to severe forms of COVID-19 due to pre-existing conditions and more likely to contract the virus due to limited access to water and soap, hand sanitizer and face masks, the inability to physically distance and suboptimal access to healthcare.'

The Lancet Regional Health Europe
Maximising public adherence to COVID-19 self-isolation in Europe

In conclusion, 'COVID-19 has exacerbated inequalities and there are individuals and whole communities that cannot isolate without adequate financial and practical support that is easily accessible. We must accept this reality and unequivocally push for measures that support this critical behaviour.'

19 April 2021

European Journal of Public Health
COVID-SCORE Spain: Public perceptions of key government COVID-19 control measures

This article concludes that fostering public trust during health threats may improve perception of response efforts. Future efforts should tailor interventions that consider gender, education level, and whether people have been affected by COVID-19.

Leave no one behind: ensuring access to COVID-19 vaccines for refugee and displaced populations

'As the world confronts one of the most formidable public-health challenges in recent history, how we respond today will determine not only the course of this pandemic but also who benefits from public-health advances for years to come. We may further entrench the inequities and distrust experienced by refugees and displaced populations around the world, or, by recognizing and confronting these inequities, we can build stronger, fairer health systems that are better prepared to respond to COVID-19 and future health emergencies.'

15 April 2021

COVID-19 response: mitigating negative impacts on other areas of health

This analysis concludes that the lack of attention to the broader health system and health impacts of vertical response measures, particularly under lockdowns—but also other elements of public health responses which, while less directly disruptive than lockdowns, may still have blind spots—has resulted in and will continue to cause significant harm to health and well-being.

14 April 2021

International Journal of Public Health
Toward ‘Vaccine Internationalism’: The Need for an Equitable and Coordinated Global Vaccination Approach to Effectively Combat COVID-19

'ASPHER calls upon civil society organisations (CSOs) and schools of public health to support the WHO and national governments in catalyzing efforts to combat the spread of disinformation and misinformation. CSOs and schools of public health must not only continue to convey factual, evidence-based information, but also identify and share best practices and expertise with policymakers.'

COVID-19 Vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues

As announced last week, EMA’s safety committee (PRAC) is reviewing very rare cases of unusual blood clots that occurred in the United States following the use of Janssen’s COVID-19 vaccine. 

AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets

EMA continues to monitor very rare blood clots with low blood platelets that occurred after vaccination with Vaxzevria (previously COVID-19 Vaccine AstraZeneca).

13 April 2021

The Lancet Infectious Diseases
SARS-CoV-2 incidence and vaccine escape

This paper aims to answer the following question: how can COVID-19 exit strategies be planned while limiting the vaccine escape risk?

8 April 2021

Reinfection with SARS-CoV-2: implementation of a surveillance case definition within the EU/EEA

This document presents the findings of a survey of EU/EEA countries carried out to ascertain surveillance practices implemented to document and report suspected reinfection cases. It summarises the available evidence on the duration of protective immunity following infection with SARS-CoV-2, addressing concerns related to reinfection, such as disease severity during a reinfection episode. The survey responses and available evidence are used to underline the rationale for the surveillance case definition proposed for suspected reinfection cases, to be reported via The European Surveillance System (TESSy).

7 April 2021

AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets

EMA’s safety committee (PRAC) has concluded today that unusual blood clots with low blood platelets should be listed as very rare side effects of Vaxzevria (formerly COVID-19 Vaccine AstraZeneca). However, EMA confirms overall benefit-risk remains positive.

1 April 2021

European Journal of Public Health
Area-level indicators of income and total mortality during the COVID-19 pandemic

The authors conducted an ecological study based on the number of deaths registered in the municipalities of the Lombardy region (Italy) between January 2019 and June 2020. In conclusion, the socioeconomic inequalities in mortality widened in Lombardy, the Italian region most severely hit during the first phase of the COVID-19 pandemic.

Covid-19 vaccine passports: access, equity, and ethics

'While the merits of vaccine passports may be undeniable, implementation will require ethical justifications and practical solutions that do not discriminate against the poor, the less technically literate, and people from low- and middle-income countries. Without mitigation strategies and alternative solutions, the hardships experienced by marginalised and vulnerable groups will be intensified through the perpetuation of discrimination.'

31 March 2021

Vaccines explained series

WHO's 'Vaccine Explained' series features illustrated articles on vaccine development and distribution. Learn more about vaccines from the earliest of research stages to their rollout in countries.

30 March 2021

WHO-convened global study of origins of SARS-CoV-2: China Part

26 March 2021

Covid-19: Vaccine hesitancy fell after vaccination programme started

'More than eight out of 10 UK adults who were initially reluctant to have a covid vaccine now plan to do so, survey data suggest.
Preliminary findings from University College London’s Virus Watch study suggest that 86% of those who were unsure about having the vaccine or planned to refuse it in December 2020 have now changed their minds.'

Transmission of COVID-19: latest updates

Latest evidence on SARS-CoV-2 transmission and children, and on transmission in educational settings.

25 March 2021

The Lancet
COVID-19 vaccines for the European region: an unprecedented challenge

In this paper, Hans Kluge and Martin McKee explain that 'The logistics of delivering vaccination to the intended groups is complex. Many things need to be in place, including accurate population registers, systems to identify groups with low uptake, adequate numbers of vaccinators, with removal of restrictive rules on who can administer vaccines that remain in some countries, and well functioning logistics systems for vaccines deployment.'

24 March 2021

European Commission
Commission strengthens transparency and authorisation mechanism for exports of COVID-19 vaccines

'The European Commission has introduced the principles of reciprocity and proportionality as new criteria to be considered for authorising exports under the transparency and authorisation mechanism for COVID-19 vaccine exports. This system has significantly improved the transparency of exports. Nevertheless, the objective to ensure timely access to COVID-19 vaccines for EU citizens is still not met.'

23 March 2021

European Parliament
COVID-19 vaccines: MEPs quiz top officials on authorisation and contracts

MEPs quizzed the European Commission and European Medicines Agency on the latest developments concerning the authorisation and purchase of COVID-19 vaccines.

European Journal of Public Health
Assessing the Indirect Effects of COVID-19 on Healthcare Delivery, Utilization, and Health Outcomes: A Scoping Review

Healthcare utilization for non-COVID-19 conditions has decreased almost universally, across both high- and lower-income countries. The pandemic’s impact on non-COVID-19 health outcomes, particularly for chronic diseases, may take years to fully manifest and should be a topic of ongoing study. 

Covid-19: variants and vaccination

Current vaccines are based on a version of the spike glycoprotein from the start of the outbreak, however, and central questions remain around the ability of an old version of the spike glycoprotein to generate protective antibodies against newer emerging variants. 

22 March 2021

Post-acute COVID-19 syndrome

In this article, the authors provide a comprehensive review of the current literature on post-acute COVID-19, its pathophysiology and its organ-specific sequelae. They discuss relevant considerations for the multidisciplinary care of COVID-19 survivors and propose a framework for the identification of those at high risk for post-acute COVID-19 and their coordinated management through dedicated COVID-19 clinics.

21 March 2021

The Lancet
Prisons need to be included in global and national vaccinations effort against COVID-19

'People in detention are more vulnerable to severe forms of COVID-19 due to pre-existing conditions and more likely to contract the virus due to limited access to water and soap, hand sanitizer and face masks, the inability to physically distance and suboptimal access to healthcare. Moreover, most people spend limited time in prison and transition between community and prison, including staff moving daily in and out of the premises, which leads to increased risk of the virus entering prison and spilling into communities, demanding specific prevention measures.'

Maximising public adherence to COVID-19 self-isolation in Europe
Drawing on analyses of international approaches to self-isolation measures, [the authors] distil five key insights for maximising public adherence to self-isolation in the European region.

Joint ECDC - WHO Regional Office for Europe Weekly COVID-19 Surveillance Bulletin

Week 15-21 March

20 March 2021

The Lancet Regional Health / Europe
Do asymptomatic carriers of SARS-COV-2 transmit the virus?

'[The authors} suggest that asymptomatic individuals are infectious during the early stage of infection, but some rare cases (3/100.000) become long-term virus carriers which are no longer infectious. [...] It cannot be excluded that rare long-term carriers may become virus reservoirs, with the potential to cause recurrent outbreaks. This has important implications for future SARS-COV-2 public health and surveillance, and our understanding of yet another pitfall of this cunning virus.'

18 March 2021

European Commission
Statement following the European Medicines Agency review of the COVID-19 vaccine AstraZeneca

'As the European Medicines Agency has clearly stated today, the benefits of the vaccine in combating COVID-19 continue to outweigh the risks of side effects. It is an effective and safe vaccine that greatly contributes to the efforts to address the impact of COVID-19 and the very serious health risks of an infection.'

17 March 2021

European Commission
Coronavirus: a common path to Europe's safe re-opening

The Commission has adopted a legislative proposal establishing a common framework for a Digital Green Certificate covering vaccination, testing and recovery.The Digital Green Certificate will be a proof that a person has been vaccinated against COVID-19, received a negative test result or recovered from COVID-19. It will be available, free of charge, in digital or paper format.

Questions and Answers – Digital Green Certificate

15 March 2021

European Medicines Agency
EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events – further update

'Several authorities responsible for national vaccine campaigns in EU countries have temporarily paused vaccination with COVID-19 Vaccine AstraZeneca. This is a precaution taken in the light of their national situation while EMA investigates a number of events of blood clots in people who had received the vaccine, as previously reported.'

WHO / Europe
Dashboard: COVID-19 situation in the WHO European Region

13 March 2021

The Lancet
Access to COVID-19 vaccines: looking beyond COVAX

'Global vaccination is essential to ending the pandemic but this fact has still not prompted the unity required to deliver it. Far more vision and ambition are needed. They must come from the highest political levels.'

12 March 2021

The Lancet Infectious Diseases
A glimmer of hope beyond the spring for Europe

'When the COVID-19 pandemic hit Europe in early 2020, people were forced, for the first time, to comply with what were perceived as Orwellian, almost nightmarish, restrictions. Yet, Europeans adapted to the restrictions bravely, and the scenes of people singing together from their balconies or playing tennis on rooftops were uplifting and created a sense of unity and common purpose. 1 year later, feelings in the continent are quite different.'

11 March 2021

European Commission
Commission extends transparency and authorisation mechanism for exports of COVID-19 vaccines

The Commission has today extended until end of June the transparency and authorisation mechanism for COVID-19 vaccine exports. This follows persistent delays in some of the deliveries of vaccines to the EU.

European Commission
European Commission authorises fourth safe and effective vaccine against COVID-19

The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and the fourth COVID-19 vaccine authorised in the EU.

The Lancet Regional Health / Europe
Is the worst of the pandemic over for Europe?

'To truly leave the pandemic behind, the world needs the poorest of the poor and the richest of the rich to have equal access to the vaccines, and Europe has a crucial role to play in this philanthropic mission. A reassuring pledge has been made by the world leaders at the virtual G7 meeting on Feb 19, to donate a part of their vaccine supplies to the developing nations. Only time can tell if these promises will be fulfilled.'

10 March 2021

European Commission
Commission supports Member States in tackling coronavirus hotspots with offer of four million additional doses of BioNTech-Pfizer vaccine to be delivered this month

The European Commission has reached an agreement with BioNTech-Pfizer for the supply of four million more doses of COVID-19 vaccines for Member States in the next two weeks in order to tackle coronavirus hotspots and to facilitate free border movement.

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

'The probability that the risk of mortality is increased by infection with VOC-202012/01 is high. If this finding is generalisable to other populations, infection with VOC-202012/1 has the potential to cause substantial additional mortality compared with previously circulating variants. Healthcare capacity planning and national and international control policies are all impacted by this finding, with increased mortality lending weight to the argument that further coordinated and stringent measures are justified to reduce deaths from SARS-CoV-2.'

Journal of Epidemiology & Community Health
Scaling COVID-19 against inequalities: should the policy response consistently match the mortality challenge?

The authors aimed to calibrate the scale of the modelled mortality impact of COVID-19 using age-standardised mortality rates and life expectancy contribution against other, socially determined, causes of death in order to inform governments and the public.

The BMJ 
How can we improve self-isolation and quarantine for covid-19?

The authors examined the approaches to supporting and monitoring isolation in countries with available data to help understand what works. Data sources included government reports and websites, peer reviewed articles, preprints, and news media reports.

The Lancet
School reopening without robust COVID-19 mitigation risks accelerating the pandemic

'Multi-layered mitigations can substantially reduce the risk of transmission within schools and into households. In the panel we [the authors] summarise a set of recommendations that are in line with guidelines from the US Centers for Disease Control and Prevention (CDC) and practised in many countries to reduce the risk of transmission in schools and mitigate the impact of COVID-19 on children and families.'

9 March 2021

Journal of Public Health 
Acceptance of a Covid-19 vaccine is associated with ability to detect fake news and health literacy

'To promote acceptance of a vaccine against SARS-CoV-2, it is recommended to increase individuals’ ability to detect fake news and health literacy through education and communication programs.'

8 March 2021

EUPHA signs the advocacy statement on the Need for Knowledge Sharing and Collaboration in the Fight Against COVID-19

The World Federation of Public Health Associations, the Alliance of Public Health Associations of the Americas, the European Public Health Association, the African Federation of Public Health Associations, and the Asia Pacific Regional Liaison Office call on regional societies and national public health associations to re-emphasize their commitment to collaboration and to continue strengthening global partnerships.

Inspiring change: women’s leadership in health care is vital during the COVID-19 pandemic and beyond

COVID-19 continues to exacerbate existing inequalities and place a disproportionate burden on women, including in health-care settings. Women health workers are faced with increased workloads, a gender pay gap, shortages of personal protective equipment that fits them, and harassment and violence as they respond to the pandemic on the frontlines.

The Lancet Global Health
COVID-19 serosurveys for public health decision making

COVID-19 vaccination is being rolled out in many countries. Serosurveys will continue to be of great use for understanding population immunity on account of natural infection as well as vaccination and ongoing transmission.

5 March 2021

European Commission
International Women's Day 2021: COVID-19 pandemic is a major challenge for gender equality

Ahead of International Women's Day, the Commission published its 2021 report on gender equality in the EU, that shows the negative impact of the COVID-19 pandemic on women. The pandemic has exacerbated existing inequalities between women and men in almost all areas of life, both in Europe and beyond, rolling back on the hard-won achievements of past years.

3 March 2021

London School of Hygiene and Tropical Medicine
VaC tracker

The LSHTM VaC tracker is focused on presenting a comprehensive and up-to-date overview of the global vaccine landscape, provided in a user-friendly and engaging format. The landscape feature is updated weekly, collating information on all preclinical and clinical candidates from the WHO COVID-19 vaccine landscape and the Milken Institute's tracker, as well as information provided directly by developers. An interactive timeline displays clinical trial dates and locations for each candidate, providing users with the option to subset vaccines by platform and development phase.

The Lancet Global Health
Preparing for COVID-19 vaccine roll-out through simulation exercises

'Both vaccine-specific tabletop exercises and intra-action review adopt a whole-of-society approach that involves different sectors of the government, private and public sectors, community organisations, and academia to conduct studies to understand vaccine hesitancy and how to promote positive behaviour change. Hence, being one of the biggest vaccination endeavours in history, everyone needs to be on board. By working together, being prepared, and staying one step ahead, we can prevail in the fight against COVID-19.'

COVID-19: use intersectional analyses to close gaps in outcomes and vaccination

The authors call for an intersectional approach to COVID-19 research and vaccination programmes to better serve people. Socially, gender, race, ethnicity, disability, class and geography are key mediators of exposure to SARS-CoV-2, access to care and the impact of lockdowns. Biologically, age, male sex, obesity and co-morbidities are important risk factors for severe disease and mortality. More investigation is needed on how these factors interact to affect health and vaccination.

Methods for the detection and identification of SARS-CoV-2 variants

This technical guidance provides guidance to laboratories, microbiology experts and relevant stakeholders in making decisions on establishing or scaling up capability and capacity to detect and identify circulating SARS-CoV-2 variants, and in making decisions on which technologies to use and for which objective.

1 March 2021

The Lancet Regional Health Europe
Evidencing the detrimental impact of the COVID-19 pandemic on mental health across Europe

As vaccination programmes are rolled out across the continent, and the immediate impact of COVID-19 gradually abates, comprehensive public health strategies will need to optimise societal well-being, health and prosperity by carefully balancing the complex trade-offs between enhancing the mental health and life chances of younger people and working age adults whilst protecting the physical health and safety of older persons and individuals with existing serious physical health conditions

26 February 2021

European Commission
Coronavirus: First EU disinfection robots arrive in hospitals

Two Slovenian hospitals received two of the first robots purchased by the Commission to disinfect patient rooms, thus helping reduce and contain the spread of coronavirus. A further 29 disinfection robots are deployed to hospitals in Belgium, Denmark, Germany, Estonia, Ireland, Greece, Spain, Croatia, Lithuania, Luxembourg and the Netherlands. These robots can disinfect a standard size patient room in as quickly as 10 minute